APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic Analgesics

Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

Selected research

Market Structure

Global Antipyretic Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025190 pages

Choose your research edition.

Industry ResearchAntipyretic Analgesics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic Analgesics Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Antipyretic Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic Analgesics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic Analgesics Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.

Antipyretic analgesic of the world's main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.

Read the full market overview

This report provides an overview of the global Antipyretic Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antipyretic Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antipyretic Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antipyretic Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Antipyretic Analgesics Segment by Company

Mallinckrodt Pharmaceuticals

IOL

Anqiu Lu'an Pharmaceutical

Novacyl

BASF

Anhui BBCA Pharmaceuticals

Hubei Biocause

Xinhua Pharm

Granules India Limited

Huagang Pharm

Hebei Jiheng Pharmaceutical

Zhejiang Kangle Pharmaceutical

Hebei Jingye Medical Technology

MSPF

Antipyretic Analgesics Segment by Type

Paracetamol

Aspirin

Ibuprofen

Naproxen

Diclofenac

Oxaprozin

Dexibuprofen

Others

Antipyretic Analgesics Segment by Application

Adults

Children

Antipyretic Analgesics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antipyretic Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antipyretic Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antipyretic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antipyretic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antipyretic Analgesics Industry Trends Table 2. Antipyretic Analgesics Industry Drivers Table 3. Antipyretic Analgesics Industry Opportunities and Challenges Table 4. Antipyretic Analgesics Industry Restraints Table 5. Global Antipyretic Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antipyretic Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antipyretic Analgesics Sales by Manufacturers (MT) & (2021-2026) Table 8. Global Antipyretic Analgesics Sales Market Share by Manufacturers Table 9. Global Antipyretic Analgesics Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Antipyretic Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antipyretic Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antipyretic Analgesics Manufacturers, Product Type & Application Table 13. Global Antipyretic Analgesics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antipyretic Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Paracetamol Table 17. Major Manufacturers of Aspirin Table 18. Major Manufacturers of Ibuprofen Table 19. Major Manufacturers of Naproxen Table 20. Major Manufacturers of Diclofenac Table 21. Major Manufacturers of Oxaprozin Table 22. Major Manufacturers of Dexibuprofen Table 23. Major Manufacturers of Others Table 24. Global Antipyretic Analgesics Sales by Type 2021 VS 2025 VS 2032 (MT) Table 25. Global Antipyretic Analgesics Sales by Type (2021-2026) & (MT) Table 26. Global Antipyretic Analgesics Sales by Type (2027-2032) & (MT) Table 27. Global Antipyretic Analgesics Sales Market Share by Type (2021-2026) Table 28. Global Antipyretic Analgesics Sales Market Share by Type (2027-2032) Table 29. Global Antipyretic Analgesics Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 30. Global Antipyretic Analgesics Revenue by Type (2021-2026) & (MT) Table 31. Global Antipyretic Analgesics Revenue by Type (2027-2032) & (MT) Table 32. Global Antipyretic Analgesics Revenue Market Share by Type (2021-2026) Table 33. Global Antipyretic Analgesics Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Adults Table 35. Major Manufacturers of Children Table 36. Global Antipyretic Analgesics Sales by Application 2021 VS 2025 VS 2032 (MT) Table 37. Global Antipyretic Analgesics Sales by Application (2021-2026) & (MT) Table 38. Global Antipyretic Analgesics Sales by Application (2027-2032) & (MT) Table 39. Global Antipyretic Analgesics Sales Market Share by Application (2021-2026) Table 40. Global Antipyretic Analgesics Sales Market Share by Application (2027-2032) Table 41. Global Antipyretic Analgesics Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 42. Global Antipyretic Analgesics Revenue by Application (2021-2026) & (MT) Table 43. Global Antipyretic Analgesics Revenue by Application (2027-2032) & (MT) Table 44. Global Antipyretic Analgesics Revenue Market Share by Application (2021-2026) Table 45. Global Antipyretic Analgesics Revenue Market Share by Application (2027-2032) Table 46. Global Antipyretic Analgesics Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 47. Global Antipyretic Analgesics Sales by Region (2021-2026) & (MT) Table 48. Global Antipyretic Analgesics Sales Market Share by Region (2021-2026) Table 49. Global Antipyretic Analgesics Sales Forecasted by Region (2027-2032) & (MT) Table 50. Global Antipyretic Analgesics Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Antipyretic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 52. North America Antipyretic Analgesics Sales by Country (2021-2026) & (MT) Table 53. North America Antipyretic Analgesics Sales by Country (2027-2032) & (MT) Table 54. Europe Antipyretic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 55. Europe Antipyretic Analgesics Sales by Country (2021-2026) & (MT) Table 56. Europe Antipyretic Analgesics Sales by Country (2027-2032) & (MT) Table 57. Asia Pacific Antipyretic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 58. Asia Pacific Antipyretic Analgesics Sales by Country (2021-2026) & (MT) Table 59. Asia Pacific Antipyretic Analgesics Sales by Country (2027-2032) & (MT) Table 60. South America, Middle East and Africa Antipyretic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 61. South America, Middle East and Africa Antipyretic Analgesics Sales by Country (2021-2026) & (MT) Table 62. South America, Middle East and Africa Antipyretic Analgesics Sales by Country (2027-2032) & (MT) Table 63. Global Antipyretic Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Antipyretic Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Antipyretic Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Antipyretic Analgesics Revenue Market Share by Region (2021-2026) Table 67. Global Antipyretic Analgesics Revenue Market Share by Region (2027-2032) Table 68. Mallinckrodt Pharmaceuticals Company Information Table 69. Mallinckrodt Pharmaceuticals Business Overview Table 70. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio Table 72. Mallinckrodt Pharmaceuticals Recent Development Table 73. IOL Company Information Table 74. IOL Business Overview Table 75. IOL Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. IOL Antipyretic Analgesics Product Portfolio Table 77. IOL Recent Development Table 78. Anqiu Lu'an Pharmaceutical Company Information Table 79. Anqiu Lu'an Pharmaceutical Business Overview Table 80. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio Table 82. Anqiu Lu'an Pharmaceutical Recent Development Table 83. Novacyl Company Information Table 84. Novacyl Business Overview Table 85. Novacyl Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novacyl Antipyretic Analgesics Product Portfolio Table 87. Novacyl Recent Development Table 88. BASF Company Information Table 89. BASF Business Overview Table 90. BASF Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. BASF Antipyretic Analgesics Product Portfolio Table 92. BASF Recent Development Table 93. Anhui BBCA Pharmaceuticals Company Information Table 94. Anhui BBCA Pharmaceuticals Business Overview Table 95. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio Table 97. Anhui BBCA Pharmaceuticals Recent Development Table 98. Hubei Biocause Company Information Table 99. Hubei Biocause Business Overview Table 100. Hubei Biocause Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hubei Biocause Antipyretic Analgesics Product Portfolio Table 102. Hubei Biocause Recent Development Table 103. Xinhua Pharm Company Information Table 104. Xinhua Pharm Business Overview Table 105. Xinhua Pharm Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Xinhua Pharm Antipyretic Analgesics Product Portfolio Table 107. Xinhua Pharm Recent Development Table 108. Granules India Limited Company Information Table 109. Granules India Limited Business Overview Table 110. Granules India Limited Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Granules India Limited Antipyretic Analgesics Product Portfolio Table 112. Granules India Limited Recent Development Table 113. Huagang Pharm Company Information Table 114. Huagang Pharm Business Overview Table 115. Huagang Pharm Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Huagang Pharm Antipyretic Analgesics Product Portfolio Table 117. Huagang Pharm Recent Development Table 118. Hebei Jiheng Pharmaceutical Company Information Table 119. Hebei Jiheng Pharmaceutical Business Overview Table 120. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio Table 122. Hebei Jiheng Pharmaceutical Recent Development Table 123. Zhejiang Kangle Pharmaceutical Company Information Table 124. Zhejiang Kangle Pharmaceutical Business Overview Table 125. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio Table 127. Zhejiang Kangle Pharmaceutical Recent Development Table 128. Hebei Jingye Medical Technology Company Information Table 129. Hebei Jingye Medical Technology Business Overview Table 130. Hebei Jingye Medical Technology Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio Table 132. Hebei Jingye Medical Technology Recent Development Table 133. MSPF Company Information Table 134. MSPF Business Overview Table 135. MSPF Antipyretic Analgesics Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. MSPF Antipyretic Analgesics Product Portfolio Table 137. MSPF Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Antipyretic Analgesics Distributors List Table 141. Antipyretic Analgesics Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Antipyretic Analgesics Product Image Figure 2. Global Antipyretic Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antipyretic Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Antipyretic Analgesics Sales (2021-2032) & (MT) Figure 5. Global Antipyretic Analgesics Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Antipyretic Analgesics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Paracetamol Image Figure 9. Aspirin Image Figure 10. Ibuprofen Image Figure 11. Naproxen Image Figure 12. Diclofenac Image Figure 13. Oxaprozin Image Figure 14. Dexibuprofen Image Figure 15. Others Image Figure 16. Global Antipyretic Analgesics Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 17. Global Antipyretic Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Antipyretic Analgesics Sales Market Share by Type (2021-2032) Figure 19. Global Antipyretic Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 20. Global Antipyretic Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antipyretic Analgesics Revenue Market Share by Type (2021-2032) Figure 22. Adults Image Figure 23. Children Image Figure 24. Global Antipyretic Analgesics Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 25. Global Antipyretic Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Antipyretic Analgesics Sales Market Share by Application (2021-2032) Figure 27. Global Antipyretic Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 28. Global Antipyretic Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Antipyretic Analgesics Revenue Market Share by Application (2021-2032) Figure 30. North America Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 31. North America Antipyretic Analgesics Sales Market Share by Country (2021-2032) Figure 32. U.S. Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 33. Canada Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 34. Mexico Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 35. Europe Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 36. Europe Antipyretic Analgesics Sales Market Share by Country (2021-2032) Figure 37. Germany Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 38. France Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 39. U.K. Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 40. Italy Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 41. Netherlands Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 42. Asia Pacific Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 43. Asia Pacific Antipyretic Analgesics Sales Market Share by Country (2021-2032) Figure 44. China Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 45. Japan Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 46. South Korea Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 47. Southeast Asia Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 48. India Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 49. Australia Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 50. South America, Middle East and Africa Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 51. South America, Middle East and Africa Antipyretic Analgesics Sales Market Share by Country (2021-2032) Figure 52. Brazil Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 53. South Africa Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 54. Saudi Arabia Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 55. Turkey Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 56. Argentina Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 57. UAE Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 58. Egypt Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 59. Chile Antipyretic Analgesics Sales and Growth Rate (2021-2032) & (MT) Figure 60. Global Antipyretic Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Antipyretic Analgesics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Antipyretic Analgesics Revenue (2021-2032) & (US$ Million) Figure 63. North America Antipyretic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Antipyretic Analgesics Revenue (2021-2032) & (US$ Million) Figure 65. Europe Antipyretic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Antipyretic Analgesics Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Antipyretic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Antipyretic Analgesics Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Antipyretic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Antipyretic Analgesics Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Antipyretic Analgesics Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Paracetamol
  • Aspirin
  • Ibuprofen
  • Naproxen
  • Diclofenac
  • Oxaprozin
  • Dexibuprofen
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Mallinckrodt Pharmaceuticals
  • IOL
  • Anqiu Lu'an Pharmaceutical
  • Novacyl
  • BASF
  • Anhui BBCA Pharmaceuticals
  • Hubei Biocause
  • Xinhua Pharm
  • Granules India Limited
  • Huagang Pharm
  • Hebei Jiheng Pharmaceutical
  • Zhejiang Kangle Pharmaceutical
  • Hebei Jingye Medical Technology
  • MSPF

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antipyretic Analgesics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antipyretic Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antipyretic Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antipyretic Analgesics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antipyretic Analgesics Market Dynamics
  1. 2.1 Antipyretic Analgesics Industry Trends
  2. 2.2 Antipyretic Analgesics Industry Drivers
  3. 2.3 Antipyretic Analgesics Industry Opportunities and Challenges
  4. 2.4 Antipyretic Analgesics Industry Restraints
3 Antipyretic Analgesics Market by Manufacturers
  1. 3.1 Global Antipyretic Analgesics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antipyretic Analgesics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antipyretic Analgesics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antipyretic Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antipyretic Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antipyretic Analgesics Manufacturers, Product Type & Application
  7. 3.7 Global Antipyretic Analgesics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antipyretic Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antipyretic Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antipyretic Analgesics Tier 1, Tier 2, and Tier 3
4 Antipyretic Analgesics Market by Type
  1. 4.1 Antipyretic Analgesics Type Introduction
  2. 4.1.1 Paracetamol
  3. 4.1.2 Aspirin
  4. 4.1.3 Ibuprofen
  5. 4.1.4 Naproxen
  6. 4.1.5 Diclofenac
  7. 4.1.6 Oxaprozin
  8. 4.1.7 Dexibuprofen
  9. 4.1.8 Others
  10. 4.2 Global Antipyretic Analgesics Sales by Type
  11. 4.2.1 Global Antipyretic Analgesics Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Antipyretic Analgesics Sales by Type (2021-2032)
  13. 4.2.3 Global Antipyretic Analgesics Sales Market Share by Type (2021-2032)
  14. 4.3 Global Antipyretic Analgesics Revenue by Type
  15. 4.3.1 Global Antipyretic Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Antipyretic Analgesics Revenue by Type (2021-2032)
  17. 4.3.3 Global Antipyretic Analgesics Revenue Market Share by Type (2021-2032)
5 Antipyretic Analgesics Market by Application
  1. 5.1 Antipyretic Analgesics Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Antipyretic Analgesics Sales by Application
  5. 5.2.1 Global Antipyretic Analgesics Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antipyretic Analgesics Sales by Application (2021-2032)
  7. 5.2.3 Global Antipyretic Analgesics Sales Market Share by Application (2021-2032)
  8. 5.3 Global Antipyretic Analgesics Revenue by Application
  9. 5.3.1 Global Antipyretic Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antipyretic Analgesics Revenue by Application (2021-2032)
  11. 5.3.3 Global Antipyretic Analgesics Revenue Market Share by Application (2021-2032)
6 Global Antipyretic Analgesics Sales by Region
  1. 6.1 Global Antipyretic Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antipyretic Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Antipyretic Analgesics Sales by Region (2021-2026)
  4. 6.2.2 Global Antipyretic Analgesics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antipyretic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antipyretic Analgesics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antipyretic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antipyretic Analgesics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antipyretic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antipyretic Analgesics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antipyretic Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antipyretic Analgesics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antipyretic Analgesics Revenue by Region
  1. 7.1 Global Antipyretic Analgesics Revenue by Region
  2. 7.1.1 Global Antipyretic Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antipyretic Analgesics Revenue by Region (2021-2026)
  4. 7.1.3 Global Antipyretic Analgesics Revenue by Region (2027-2032)
  5. 7.1.4 Global Antipyretic Analgesics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antipyretic Analgesics Revenue (2021-2032)
  8. 7.2.2 North America Antipyretic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antipyretic Analgesics Revenue (2021-2032)
  11. 7.3.2 Europe Antipyretic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antipyretic Analgesics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antipyretic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antipyretic Analgesics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antipyretic Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Mallinckrodt Pharmaceuticals
  2. 8.1.1 Mallinckrodt Pharmaceuticals Company Information
  3. 8.1.2 Mallinckrodt Pharmaceuticals Business Overview
  4. 8.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
  6. 8.1.5 Mallinckrodt Pharmaceuticals Recent Developments
  7. 8.2 IOL
  8. 8.2.1 IOL Company Information
  9. 8.2.2 IOL Business Overview
  10. 8.2.3 IOL Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IOL Antipyretic Analgesics Product Portfolio
  12. 8.2.5 IOL Recent Developments
  13. 8.3 Anqiu Lu'an Pharmaceutical
  14. 8.3.1 Anqiu Lu'an Pharmaceutical Company Information
  15. 8.3.2 Anqiu Lu'an Pharmaceutical Business Overview
  16. 8.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
  18. 8.3.5 Anqiu Lu'an Pharmaceutical Recent Developments
  19. 8.4 Novacyl
  20. 8.4.1 Novacyl Company Information
  21. 8.4.2 Novacyl Business Overview
  22. 8.4.3 Novacyl Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novacyl Antipyretic Analgesics Product Portfolio
  24. 8.4.5 Novacyl Recent Developments
  25. 8.5 BASF
  26. 8.5.1 BASF Company Information
  27. 8.5.2 BASF Business Overview
  28. 8.5.3 BASF Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BASF Antipyretic Analgesics Product Portfolio
  30. 8.5.5 BASF Recent Developments
  31. 8.6 Anhui BBCA Pharmaceuticals
  32. 8.6.1 Anhui BBCA Pharmaceuticals Company Information
  33. 8.6.2 Anhui BBCA Pharmaceuticals Business Overview
  34. 8.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
  36. 8.6.5 Anhui BBCA Pharmaceuticals Recent Developments
  37. 8.7 Hubei Biocause
  38. 8.7.1 Hubei Biocause Company Information
  39. 8.7.2 Hubei Biocause Business Overview
  40. 8.7.3 Hubei Biocause Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hubei Biocause Antipyretic Analgesics Product Portfolio
  42. 8.7.5 Hubei Biocause Recent Developments
  43. 8.8 Xinhua Pharm
  44. 8.8.1 Xinhua Pharm Company Information
  45. 8.8.2 Xinhua Pharm Business Overview
  46. 8.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Xinhua Pharm Antipyretic Analgesics Product Portfolio
  48. 8.8.5 Xinhua Pharm Recent Developments
  49. 8.9 Granules India Limited
  50. 8.9.1 Granules India Limited Company Information
  51. 8.9.2 Granules India Limited Business Overview
  52. 8.9.3 Granules India Limited Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Granules India Limited Antipyretic Analgesics Product Portfolio
  54. 8.9.5 Granules India Limited Recent Developments
  55. 8.10 Huagang Pharm
  56. 8.10.1 Huagang Pharm Company Information
  57. 8.10.2 Huagang Pharm Business Overview
  58. 8.10.3 Huagang Pharm Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Huagang Pharm Antipyretic Analgesics Product Portfolio
  60. 8.10.5 Huagang Pharm Recent Developments
  61. 8.11 Hebei Jiheng Pharmaceutical
  62. 8.11.1 Hebei Jiheng Pharmaceutical Company Information
  63. 8.11.2 Hebei Jiheng Pharmaceutical Business Overview
  64. 8.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
  66. 8.11.5 Hebei Jiheng Pharmaceutical Recent Developments
  67. 8.12 Zhejiang Kangle Pharmaceutical
  68. 8.12.1 Zhejiang Kangle Pharmaceutical Company Information
  69. 8.12.2 Zhejiang Kangle Pharmaceutical Business Overview
  70. 8.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
  72. 8.12.5 Zhejiang Kangle Pharmaceutical Recent Developments
  73. 8.13 Hebei Jingye Medical Technology
  74. 8.13.1 Hebei Jingye Medical Technology Company Information
  75. 8.13.2 Hebei Jingye Medical Technology Business Overview
  76. 8.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
  78. 8.13.5 Hebei Jingye Medical Technology Recent Developments
  79. 8.14 MSPF
  80. 8.14.1 MSPF Company Information
  81. 8.14.2 MSPF Business Overview
  82. 8.14.3 MSPF Antipyretic Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MSPF Antipyretic Analgesics Product Portfolio
  84. 8.14.5 MSPF Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antipyretic Analgesics Value Chain Analysis
  2. 9.1.1 Antipyretic Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antipyretic Analgesics Production Mode & Process
  6. 9.2 Antipyretic Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antipyretic Analgesics Distributors
  9. 9.2.3 Antipyretic Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst